Search

A validated risk stratification tool to categorize CKD patients intending to fast during Ramadan into low, moderate, and high-risk groups.

Calculate stdKt/V instantly with minimal inputs. Optional patient details for Residual Function.

The definitive tool for calculating weekly stdKt/V. Supports Machine-Delivered spKt/V, Lab-Calculated spKt/V (Daugirdas II), and measured Residual Renal Function.

Interprets relapse risk based on ANCA specificity (PR3 vs MPO) and disease phenotype.

Generates a structured HPI, lab summary, and plan from unstructured clinical notes, tailored to your specialty.

Calculates severity of Fabry disease across general, neurological, cardiovascular, and renal domains.

Predicts risk of contrast-induced nephropathy post-PCI.

Risk stratification based on G1/G2 risk alleles for FSGS, HTN-CKD progression, and donor evaluation.

The ABCD² score is a clinical prediction rule used to estimate the risk of stroke in the 2 days following a transient ischemic attack (TIA). It helps guide urgent management decisions and is based on Age, Blood pressure, Clinical features, Duration of symptoms, and Diabetes.

The ABCD² score is a clinical prediction rule used to estimate the risk of stroke in the 2 days following a transient ischemic attack (TIA). It helps guide urgent management decisions and is based on Age, Blood pressure, Clinical features, Duration of symptoms, and Diabetes.

Estimates bicarbonate deficit for severe metabolic acidosis correction.

Writes a professional medical referral letter from one specialist to another based on key patient data.

Decision support for determining the utility of a repeat kidney biopsy in progressive disease.

Predicts renal prognosis and ESKD onset based on COL4A5 mutation type and inheritance pattern.

Modern standard for staging chronic kidney disease (CKD) without race

Identifies the diagnostic implications of a 'Full House' immunofluorescence pattern.

Assesses ADH activity using Urine and Serum Osmolarity difference.

Stratifies risk before contrast media exposure

Determines if immunofluorescence findings meet the criteria for Pauci-Immune GN.

Grading system (0-4) utilizing RTEC and granular casts to predict AKI severity and non-recovery.

Differentiates Pre-renal AKI from ATN using creatinine ratio.

Differentiates glomerular diseases based on the location of electron-dense deposits.

Estimates urinary supersaturation of calcium oxalate, calcium phosphate, and uric acid from 24h urine parameters.

Calculates daily protein target for ICU patients on CRRT per ESPEN guidelines.

Standardized assessment tool to quantify the impairment caused by a stroke.

Distinguishes between Minimal Change Disease and Secondary FSGS based on effacement extent.

A shortened version of the NIHSS with higher inter-rater reliability, excluding items 1a, 4, 7, and 10.

Nutritional tool to assess dietary phosphorus load and guide food choices to minimize phosphorus density.

Diagnostic aid for Distal RTA (Type 1) assessing hydrogen ion secretion.

Definitive diagnostic test for Distal RTA (Type 1).

<p>Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) is a systemic disorder of mineral and bone metabolism due to CKD. It manifests as abnormalities in calcium, phosphorus, PTH, or vitamin D metabolism; abnormalities in bone turnover, mineralization, volume, linear growth, or strength; and vascular or other soft-tissue calcification. In non-dialysis CKD (ND-CKD), the focus is on preventing the adaptive surges in FGF23 and PTH while avoiding iatrogenic harm (calcium loading, adynamic bone disease).</p>

<p>Managing Chronic Kidney Disease (CKD) patients during Ramadan requires a meticulous, individualized approach. The decision to fast is not binary; it involves a complex risk assessment balancing <b>renal physiology</b>, <b>comorbidities</b>, and <b>medication pharmacokinetics</b>. Evidence suggests that while stable CKD 1-3 patients may fast safely, CKD 4-5 and transplant patients face significant risks of acute-on-chronic kidney injury.</p>

<p>A patient presenting with Acute Kidney Injury (AKI) and a creatinine of 700 µmol/L (~7.9 mg/dL) combined with severe metabolic acidosis represents a <b>nephrologic emergency</b>. This scenario corresponds to KDIGO AKI Stage 3 and requires immediate assessment for life-threatening complications to determine the need for urgent Renal Replacement Therapy (RRT) versus medical management.</p>

<p>Bloody discharge at the peritoneal dialysis (PD) catheter exit site is a specific complication distinct from bloody dialysate (hemoperitoneum). It is most commonly caused by <b>exuberant granulation tissue (granuloma)</b> or <b>trauma</b>, but infection and cuff extrusion must be ruled out.</p>

<p><b>Peritoneal Dialysis (PD) Outflow Failure</b> is defined as a condition where the drained dialysate volume is significantly less than the infused volume. It is the second most common cause of catheter failure after peritonitis. It is typically a <b>mechanical</b> problem, distinct from ultrafiltration failure (which is a membrane transport problem).</p>

<p><b>Hepatorenal Syndrome (HRS)</b> is a reversible, functional form of acute kidney injury (AKI) that occurs in patients with advanced liver cirrhosis. It represents the extreme end of the spectrum of circulatory dysfunction in liver disease, characterized by intense renal vasoconstriction despite systemic vasodilation.</p>

<p>Renal allograft dysfunction is characterized by a rise in serum creatinine, oliguria, or new-onset proteinuria/hematuria in a kidney transplant recipient. The differential diagnosis is broad and heavily dependent on the <b>time post-transplant</b>.</p>

<p>Infection is a leading cause of morbidity and mortality in kidney transplant recipients. Vaccination offers a critical opportunity to prevent disease, but the altered immune status of these patients requires a strict strategy: <b>maximize immunity before transplantation</b> and <b>avoid live vaccines after transplantation</b>. The immunosuppressive medications required to prevent rejection also blunt the adaptive immune response to vaccines, making timing and vaccine type (live vs. inactivated) the two most important factors in management.</p>

<p>Dialysis-related amyloidosis (DRA), specifically known as Aβ2M amyloidosis, is a serious complication of long-term kidney failure characterized by the deposition of amyloid fibrils derived from beta-2 microglobulin (β2M). It predominantly affects the osteoarticular system, causing debilitating pain and functional impairment. While its prevalence has declined with modern dialysis techniques, it remains a critical consideration for patients with a long vintage of dialysis treatment.</p>

<p>Aluminum toxicity, once a common scourge of dialysis patients due to contaminated water and aluminum-based phosphate binders, is now rare but potentially devastating. It classically presents with a triad of vitamin D-resistant osteomalacia (fractures, bone pain), microcytic anemia, and dialysis dementia (encephalopathy). Diagnosis relies on demonstrating increased total body aluminum burden via the deferoxamine (DFO) stimulation test, and treatment involves chelation and elimination of exposure.</p>

<p>Managing secondary hyperparathyroidism (SHPT) in the setting of hyperphosphatemia requires a strategic, stepwise approach. Hyperphosphatemia is a direct driver of parathyroid hyperplasia and resistance to therapy. The cornerstone of management is to <b>control phosphorus first</b> to allow safe suppression of PTH without precipitating metastatic calcification or calciphylaxis. In advanced CKD (G5D), this often involves a combination of dietary restriction, phosphate binders, and calcimimetics, while using active vitamin D sterols with extreme caution.</p>

<p>Tertiary hyperparathyroidism occurs when parathyroid hyperplasia becomes autonomous, secreting excess parathyroid hormone (PTH) despite normal or elevated serum calcium levels. This is most commonly seen in long-term dialysis patients or following kidney transplantation. While calcimimetics (cinacalcet) offer a medical bridge, parathyroidectomy (PTX) remains the definitive treatment for refractory cases. The management of surgical complications, particularly 'Hungry Bone Syndrome,' is a critical competency for nephrologists.</p>

<p>Calciphylaxis, or Calcific Uremic Arteriolopathy (CUA), is a life-threatening vasculopathy characterized by calcification of cutaneous arterioles leading to painful ischemic skin necrosis. It carries a 1-year mortality rate of 45-80%, with sepsis being the leading cause of death. Management requires a rapid, aggressive, multi-disciplinary approach focusing on stopping triggers, wound care, and specific pharmacotherapy.</p>

<p><b>Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)</b> is a systemic disorder manifested by abnormalities in bone and mineral metabolism and/or extra-skeletal calcification. It represents a complex interplay between calcium, phosphate, parathyroid hormone (PTH), fibroblast growth factor-23 (FGF-23), and vitamin D. Management requires a paradigm shift from treating isolated abnormal laboratory values to a holistic approach targeting the prevention of fractures and cardiovascular events.</p>

<p><b>Severe hypercalcemia (Ca >14 mg/dL or >12 mg/dL with symptoms/AKI)</b> is a medical emergency requiring rapid stabilization. In a patient with pre-existing CKD and AKI, the diagnostic framework shifts immediately to non-parathyroid causes when PTH is suppressed, with <b>malignancy</b> being the predominant concern in this age group. Management requires a delicate balance of aggressive volume resuscitation to promote calciuresis while avoiding fluid overload in the setting of renal impairment.</p>

<p>Pregnancy in women with End-Stage Renal Disease (ESRD) is high-risk but manageable with <b>intensive hemodialysis</b>. Historical outcomes were poor, but intensified dialysis regimens have significantly improved live birth rates (up to 85-90%) and gestational age. The physiologic adaptations of pregnancy (increased blood volume, respiratory alkalosis, fetal solute generation) require specific adjustments to the standard dialysis prescription to mimic the continuous clearance of native kidneys as closely as possible.</p>

<p>Peritonitis is the most frequent serious complication of peritoneal dialysis (PD) and a leading cause of technique failure. It presents with abdominal pain and cloudy effluent. Prompt diagnosis based on ISPD criteria and immediate initiation of empiric intraperitoneal (IP) antibiotics covering both Gram-positive and Gram-negative organisms are crucial to preserve the peritoneal membrane. Exit-site infections (ESI) increase the risk of peritonitis and require aggressive management to prevent catheter loss.</p>

<p>Hypernatremia (Serum $Na^+ > 145$ mEq/L) represents a state of hyperosmolality and intracellular dehydration. The primary mechanism is a deficit of free water relative to sodium. Treatment requires a systematic approach: stabilizing hemodynamics, calculating the water deficit, and selecting the appropriate rate and type of fluid to correct the hypertonicity without causing cerebral edema.</p>

<p><b>Distal Renal Tubular Acidosis (Type 1 RTA)</b> is a classic cause of Normal Anion Gap Metabolic Acidosis (NAGMA) accompanied by hypokalemia and nephrolithiasis. It results from the inability of the alpha-intercalated cells in the distal nephron to secrete hydrogen ions ($H^+$), leading to a urine pH that is inappropriately alkaline (pH > 5.5) despite systemic acidosis.</p>

<p><b>Acute Pulmonary Edema</b> in patients with Chronic Kidney Disease (CKD) or End-Stage Renal Disease (ESRD) is a life-threatening emergency caused by either absolute volume overload (failure to excrete fluid) or acute redistribution of fluid (sympathetic surge/flash pulmonary edema). Management hinges on distinguishing between these two phenotypes.</p>

<p>Hypertensive crises represent a spectrum of urgency determined not solely by the absolute blood pressure number, but by the presence of acute <b>Target Organ Damage (TOD)</b>. Differentiating between Hypertensive Emergency and Hypertensive Urgency is critical, as the management approach differs radically: rapid, controlled titration with IV agents for emergencies versus gradual reduction with oral agents for urgencies.</p>

<p><b>Gordon's Syndrome</b>, also known as <b>Pseudohypoaldosteronism Type II (PHA II)</b>, is a rare autosomal dominant disorder characterized by the clinical triad of <b>Hypertension</b>, <b>Hyperkalemia</b>, and <b>Hyperchloremic Metabolic Acidosis</b>. It typically presents in adolescents or young adults and is often described as the 'mirror image' of Gitelman Syndrome.</p>

<p>Potassium is the primary determinant of the <b>Resting Membrane Potential (RMP)</b> of cardiac myocytes. Consequently, deviations in serum potassium levels cause predictable, life-threatening alterations in cardiac conduction and repolarization. Recognizing these patterns on ECG is a critical skill in nephrology.</p>

<p>A 17-year-old male presenting with <b>resistant hypertension</b> and <b>hypokalemia</b> requires a targeted workup for secondary causes. While Primary Aldosteronism (Conn's) is the most common endocrine cause, the finding of <b>suppressed Renin</b> AND <b>suppressed Aldosterone</b> shifts the diagnosis to a unique group of disorders known as <b>Pseudohyperaldosteronism</b>. The two classic genetic causes in this category are <b>Liddle Syndrome</b> and the <b>Syndrome of Apparent Mineralocorticoid Excess (AME)</b>.</p>

<p>Hypernatremia is a common and independent predictor of mortality in the intensive care unit. It invariably represents a state of hyperosmolality and usually results from a deficit of water relative to sodium. In the ICU, the loss of the thirst defense mechanism (due to sedation or intubation) and the administration of hypertonic fluids or high solute loads (TPN, tube feeds) are frequent precipitants.</p>

<p>Severe symptomatic hyponatremia (seizures, coma) is a medical emergency requiring immediate action to reverse cerebral edema. In the context of lung cancer, this is highly suggestive of paraneoplastic SIADH. Management requires a strict pivot from <b>acute life-saving stabilization</b> to <b>prevention of Osmotic Demyelination Syndrome (ODS)</b>.</p>

<p>Assessing peritoneal membrane function is essential for tailoring the dialysis prescription to the individual patient's physiology. The gold standard method is the <b>Peritoneal Equilibration Test (PET)</b>, first described by Twardowski. It characterizes the membrane's transport rate for small solutes (creatinine, urea) and its ultrafiltration capacity.</p>

<p><b>Hemoperitoneum</b> is defined as the presence of blood in the peritoneal effluent. While visually alarming to patients, it is often benign. However, it requires a systematic approach to rule out catastrophic intra-abdominal pathology.</p>

<p>Intradialytic hypotension (IDH) is the most common complication during hemodialysis, affecting 15-30% of sessions. It is defined as a symptomatic drop in blood pressure or an asymptomatic drop in systolic blood pressure (SBP) by <b>&gt;20 mmHg</b>, or an SBP <b>&lt;90-100 mmHg</b>.</p>

<p>Hypernatremia (Serum Sodium > 145 mEq/L) is a disorder of water balance, not sodium. It is almost always caused by a <b>free water deficit</b>, resulting from either impaired water intake (e.g., altered mental status, intubation) or excessive water loss (renal or extra-renal).</p>